Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.377 | 1.782 | 1.00000 | 1.00000 | |
RegionR2 | 0.184 | 1.782 | 0.56991 | 0.93048 | |
RegionR3 | -1.01 | 1.782 | 0.87570 | 1.00000 | |
RegionR4 | 1.075 | 1.782 | 0.34752 | 0.66849 | |
RegionR5 | -4.012 | 1.782 | 1.00000 | 1.00000 | |
RegionR6 | -1.087 | 1.782 | 0.88792 | 1.00000 | |
RegionR7 | 1.982 | 1.782 | 0.05806 | 0.46262 | |
RegionR8 | 4.245 | 1.782 | 0.00007 | 0.00630 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -2.998 | 1.782 | 0.99985 | 1.00000 | |
RegenerationR2 | -0.19 | 1.782 | 0.75806 | 0.97593 | |
RegenerationR3 | -2.112 | 1.782 | 0.09743 | 0.49970 | |
RegenerationR4 | -2.373 | 1.782 | 0.08897 | 0.46813 | |
RegenerationR5 | -0.367 | 1.782 | 0.53157 | 0.87574 | |
RegenerationR6 | -2.655 | 1.782 | 0.06610 | 0.32269 | |
RegenerationBL | -3.017 | 1.782 | 0.03754 | 0.21939 | |
RegenerationTP | -0.502 | 1.782 | 0.55933 | 0.93831 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
2. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 3.446 | 0.926 | - | - | 0.719 | 0.841 | 0.960 | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
3. | MligTC455_46942 | 372 | 7.76 | Mlig455_002919 | Neo: - Age: - Region-enriched R2: 3.849/0.00000 |
AVL9 | 3.27 | - | - | 0.784 | 0.717 | 0.988 | 0.781 | Mlig455_002919 {REF} {Length: 4630} {Pfam: Transport protein Avl9 [PF09794.11, score=355.8]; DENN domain-containing protein 11 [PF09804.11, score=30.1]; Docking domain of Afi1 for Arf3 in vesicle trafficking [PF07792.14, score=22.1]; Stabilization of polarity axis [PF08616.12, score=20.1]} {Human: ENSG00000105778, AVL9, AVL9 cell migration associated, [RH, Score=347, Expect=3e-110]} {Mouse: ENSMUSG00000029787, Avl9, AVL9 cell migration associated, [RH, Score=347, Expect=3e-110]} {Dmel: FBgn0030499, CG11178, [Score=270, Expect=8e-81]} {Celegans: WBGene00020822, T26A5.6, [RH, Score=193, Expect=5e-54]} {Smed: dd_Smed_v6_6271_0_1, dd_Smed_v6_6271_0_1, [RH, Score=216, Expect=3e-61]} {RNA1509_21868} {RNA1310_21783} {RNA815_17887} |
4. | MligTC455_12451 | 63 | 1.31 | Mlig455_008444 | Neo: - Age: - Region-enriched R8: 4.645/0.00722 |
2.78 | 0.991 | - | - | - | 0.811 | 0.978 | Mlig455_008444 {REF} {Length: 791} | |
5. | MligTC455_39000 | 222 | 4.62 | Mlig455_055114 | Neo: - Age: - Region-enriched R8: 3.634/0.01137 |
2.716 | 0.870 | - | - | - | 0.869 | 0.977 | Mlig455_055114 {REF} {Length: 3533} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=21.4]} {Smed: dd_Smed_v6_14472_0_32, dd_Smed_v6_14472_0_32, [Score=47.8, Expect=5e-09]} {RNA1509_7715} {RNA1310_20361} {RNA815_2054.1} | |
6. | MligTC455_36259 | 270 | 5.63 | Mlig455_012889 | Neo: - Age: - Region-enriched R8: 5.567/0.00000 Regeneration-depleted R6: -6.631 |
WNT7B | 2.667 | 0.967 | - | - | - | 0.753 | 0.947 | Mlig455_012889 {REF} {Length: 1741} {Pfam: wnt family [PF00110.21, score=249.8]} {Human: ENSG00000188064, WNT7B, Wnt family member 7B, [Score=153, Expect=3e-42]; ENSG00000105989, WNT2, Wnt family member 2, [Score=149, Expect=2e-40]; ENSG00000002745, WNT16, Wnt family member 16, [Score=147, Expect=1e-39]; ENSG00000154764, WNT7A, Wnt family member 7A, [Score=147, Expect=9e-40]} {Mouse: ENSMUSG00000029671, Wnt16, wingless-type MMTV integration site family, member 16, [Score=155, Expect=5e-43]; ENSMUSG00000022382, Wnt7b, wingless-type MMTV integration site family, member 7B, [Score=152, Expect=4e-42]; ENSMUSG00000022996, Wnt10b, wingless-type MMTV integration site family, member 10B, [Score=150, Expect=7e-41]} {Dmel: FBgn0284084, wg, wingless, [Score=133, Expect=4e-34]} {Celegans: WBGene00001188, egl-20, Wnt homolog, [Score=130, Expect=6e-34]} {Smed: dd_Smed_v6_28398_0_1, dd_Smed_v6_28398_0_1, [Score=214, Expect=3e-65]} {RNA1509_58183} {RNA1310_17932, RNA1509_58183} {RNA1509_58183, RNA815_30269} |
7. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 2.642 | 0.882 | - | - | 0.802 | - | 0.958 | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
8. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
2.637 | 0.951 | - | - | - | 0.770 | 0.916 | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
9. | MligTC455_14869 | 56 | 1.17 | Mlig455_041087 | Neo: - Age: - |
2.612 | 0.978 | - | - | 0.746 | - | 0.888 | Mlig455_041087 {REF} {Length: 1408} {RNA1310_35281} {RNA815_59011} | |
10. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
2.609 | 0.953 | - | - | - | 0.711 | 0.945 | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
11. | MligTC455_45095 | 685 | 14.28 | Mlig455_027545 | Neo: - Age: Down-Up-Up Region-enriched R8: 2.453/0.00108 Regeneration-downregulated BL: -7.982 Regeneration-depleted BL: -7.982 |
2.6 | 0.824 | - | - | 0.818 | 0.958 | - | Mlig455_027545 {REF} {Length: 449} {RNA1509_40580} {RNA1310_73550} {RNA815_38029} | |
12. | MligTC455_10719 | 61 | 1.26 | Mlig455_041088 | Neo: - Age: - |
2.58 | 0.967 | - | - | 0.726 | - | 0.887 | Mlig455_041088 {REF} {Length: 338} {NoTransDecoderORF} {RNA1310_18998} | |
13. | MligTC455_54086 | 101 | 2.11 | Mlig455_006583, Mlig455_006693, Mlig455_006744 | Neo: - Age: - |
CACNA2D1, CACNA2D2 | 2.536 | - | - | - | 0.870 | 0.961 | 0.705 | Mlig455_006583 {REF} {Length: 4206} {Pfam: VWA N-terminal [PF08399.13, score=65.5]; Cache domain [PF02743.20, score=54.1]; von Willebrand factor type A domain [PF13519.8, score=35.8]; von Willebrand factor type A domain [PF00092.30, score=33.2]; von Willebrand factor type A domain [PF13768.8, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=169, Expect=5e-42]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=168, Expect=1e-41]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=164, Expect=2e-40]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=171, Expect=1e-42]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=169, Expect=3e-42]; ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=166, Expect=4e-41]} {Dmel: FBgn0028863, CG4587, [Score=146, Expect=5e-35]} {Celegans: WBGene00007041, tag-180, [Score=98.6, Expect=1e-20]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [RH, Score=1425, Expect=0.0]} {RNA1509_47212} {RNA1310_2302} {RNA815_5037} Mlig455_006693 {REF} {Length: 4381} {Pfam: VWA N-terminal [PF08399.13, score=64.3]; Cache domain [PF02743.20, score=55.6]; von Willebrand factor type A domain [PF13519.8, score=35.8]; von Willebrand factor type A domain [PF00092.30, score=33.2]; von Willebrand factor type A domain [PF13768.8, score=26.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=169, Expect=8e-42]; ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=169, Expect=5e-42]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=166, Expect=8e-41]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=171, Expect=7e-43]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=169, Expect=5e-42]; ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=167, Expect=2e-41]} {Dmel: FBgn0028863, CG4587, [Score=146, Expect=4e-35]} {Celegans: WBGene00007041, tag-180, [Score=98.6, Expect=2e-20]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [RH, Score=1422, Expect=0.0]} {RNA1509_47212} {RNA1310_2302, RNA1509_47212} {RNA1509_47212, RNA815_5037} Mlig455_006744 {REF} {Length: 4200} {Pfam: VWA N-terminal [PF08399.13, score=65.5]; Cache domain [PF02743.20, score=54.1]; von Willebrand factor type A domain [PF13519.8, score=35.8]; von Willebrand factor type A domain [PF00092.30, score=33.2]; von Willebrand factor type A domain [PF13768.8, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=169, Expect=6e-42]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=168, Expect=1e-41]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=164, Expect=2e-40]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=171, Expect=2e-42]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=169, Expect=3e-42]; ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=166, Expect=4e-41]} {Dmel: FBgn0028863, CG4587, [Score=146, Expect=5e-35]} {Celegans: WBGene00007041, tag-180, [Score=98.6, Expect=1e-20]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [RH, Score=1425, Expect=0.0]} {RNA1509_47212} {RNA1310_2302} {RNA815_5037} |
14. | MligTC455_46202 | 1182 | 24.63 | Mlig455_015525 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.090 Region-enriched R7: 3.843/0.00000 Regeneration-downregulated BL: -3.302 Regeneration-depleted BL: -3.302 |
2.51 | 0.815 | - | - | - | 0.735 | 0.960 | Mlig455_015525 {REF} {Length: 2230} {RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570} {RNA1310_31635.1, RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570} {RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570, RNA815_27083.1} | |
15. | MligTC455_41824 | 194 | 4.03 | Mlig455_048229 | Neo: - Age: - Region-enriched R2: 3.040/0.03860 |
2.504 | - | - | - | 0.702 | 0.961 | 0.841 | Mlig455_048229 {REF} {Length: 769} {RNA1509_49797} {RNA1310_60350, RNA1509_49797} {RNA1509_49797, RNA815_30999} | |
16. | MligTC455_11069 | 184 | 3.83 | Mlig455_038504 | Neo: - Age: - |
2.466 | 0.980 | - | - | - | 0.762 | 0.724 | Mlig455_038504 {REF} {Length: 816} {RNA1310_51357} {RNA815_24712} | |
17. | MligTC455_04474 | 114 | 2.37 | Mlig455_039605 | Neo: - Age: logFC(26M/2M)=-0.389 Region-enriched R8: 5.608/0.00012 |
HMCN1 | 1.941 | 0.968 | - | - | - | - | 0.973 | Mlig455_039605 {REF} {Length: 4319} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=405.5]; Spondin-like TSP1 domain [PF19028.2, score=340.3]; Thrombospondin type 1 domain [PF19030.2, score=125.1]; Scavenger receptor cysteine-rich domain [PF00530.20, score=57.7]; CCN3 Nov like TSP1 domain [PF19035.2, score=48.4]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=292, Expect=4e-80]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=288, Expect=7e-79]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=156, Expect=3e-38]} {Celegans: WBGene00016468, C36B7.5, [RH, Score=199, Expect=7e-52]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=264, Expect=9e-72]} {RNA1509_12135} {RNA1310_3277, RNA1509_12135} {RNA1509_12135, RNA815_5276} |
18. | MligTC455_53638 | 2333 | 48.59 | Mlig455_051726 | Neo: - Age: Down-Up-Up Region-enriched R8: 2.691/0.00000 Regeneration-downregulated BL: -2.953 Regeneration-depleted BL: -2.953 |
1.924 | - | - | - | - | 0.965 | 0.959 | Mlig455_051726 {REF} {Length: 657} {RNA1509_6981} {RNA1310_49321} {RNA815_24877} | |
19. | MligTC455_06773 | 251 | 5.23 | Mlig455_069732 | Neo: - Age: Down-Up-Down |
1.912 | 0.966 | - | - | - | - | 0.946 | Mlig455_069732 {REF} {Length: 1347} {RNA1310_24767.1} {RNA815_33473} | |
20. | MligTC455_06772 | 238 | 4.96 | Mlig455_048772 | Neo: - Age: - Region-enriched R8: 6.268/0.00000 |
1.91 | 0.966 | - | - | - | - | 0.944 | Mlig455_048772 {REF} {Length: 839} {RNA1310_24767.2} {RNA815_33473} | |
21. | MligTC455_13746 | 200 | 4.17 | Mlig455_064975, Mlig455_066810 | Neo: - Age: - Region-enriched R8: 8.067/0.00000 |
1.907 | 0.962 | - | - | - | - | 0.945 | Mlig455_064975 {REF} {Length: 2922} {RNA1509_22976} {RNA1310_9502} {RNA815_8881} Mlig455_066810 {REF} {Length: 2922} {RNA1509_22976} {RNA1310_9502} {RNA815_8881} |
|
22. | MligTC455_14757 | 726 | 15.12 | Mlig455_043399, Mlig455_043416, Mlig455_043559, Mlig455_043567 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.347 Region-specific R8: 6.849 Region-enriched R8: 6.705/0.00000 Regeneration-downregulated BL: -8.524 Regeneration-depleted BL: -8.524 |
1.904 | 0.960 | - | - | - | - | 0.944 | Mlig455_043399 {REF} {Length: 5997} {Dmel: FBgn0010434, cora, coracle, [Score=80.5, Expect=1e-14]} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} Mlig455_043416 {REF} {Length: 6138} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} Mlig455_043559 {REF} {Length: 7159} {RNA1509_17394} {RNA1310_38694} {RNA815_21047} Mlig455_043567 {REF} {Length: 8454} {Dmel: FBgn0010434, cora, coracle, [Score=51.6, Expect=3e-06]} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} |
|
23. | MligTC455_44219 | 289 | 6.02 | Mlig455_053855 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.323 Region-enriched R8: 2.811/0.00017 |
CDH23 | 1.902 | 0.938 | - | - | - | - | 0.964 | Mlig455_053855 {REF} {Length: 9181} {Pfam: Cadherin domain [PF00028.19, score=457.3]; Cadherin-like [PF08266.14, score=40.7]} {Human: ENSG00000107736, CDH23, cadherin related 23, [Score=538, Expect=6e-156]} {Mouse: ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=536, Expect=9e-156]} {Dmel: FBgn0038247, Cad88C, Cadherin 88C, [RH, Score=635, Expect=0.0]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=240, Expect=3e-63]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [RH, Score=749, Expect=0.0]} {RNA1509_10347} {RNA1310_449.1} {RNA815_181} |
24. | MligTC455_34727 | 96 | 2 | Mlig455_041259 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.811 Region-enriched R8: 4.340/0.01025 |
GLIPR1 | 1.891 | 0.984 | - | - | 0.907 | - | - | Mlig455_041259 {REF} {Length: 5028} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=67.4]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [RH, Score=98.6, Expect=2e-22]} {Mouse: ENSMUSG00000056888, Glipr1, GLI pathogenesis-related 1 (glioma), [RH, Score=107, Expect=7e-26]} {Dmel: FBgn0038126, CG8483, [Score=52.8, Expect=5e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=67.0, Expect=6e-12]} {Smed: dd_Smed_v6_681_0_1, dd_Smed_v6_681_0_1, [Score=104, Expect=1e-25]} {RNA1509_36146} {RNA1310_23199} {RNA815_7031} |
25. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 1.89 | 0.975 | - | - | 0.915 | - | - | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
26. | MligTC455_37537 | 203 | 4.23 | Mlig455_047747 | Neo: - Age: - Region-enriched R8: 3.525/0.01192 |
KCNC2 | 1.876 | 0.992 | - | - | - | - | 0.884 | Mlig455_047747 {REF} {Length: 3532} {Pfam: Ion transport protein [PF00520.33, score=105.8]; BTB/POZ domain [PF02214.24, score=56.8]; Ion channel [PF07885.18, score=52.6]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=216, Expect=4e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=215, Expect=5e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=207, Expect=1e-56]} {Mouse: ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=1e-65]} {Celegans: WBGene00001202, egl-36, Potassium voltage-gated channel protein egl-36, [Score=211, Expect=5e-59]} {Smed: dd_Smed_v6_9740_0_2, dd_Smed_v6_9740_0_2, [Score=208, Expect=6e-58]} {RNA1509_26535} {RNA1310_14101} {RNA815_34993} |
27. | MligTC455_30850 | 34 | 0.71 | Mlig455_019341, Mlig455_019556 | Neo: - Age: logFC(26M/2M)=-0.625 |
GRIK2, GRIK4 | 1.869 | 0.976 | - | - | - | - | 0.893 | Mlig455_019341 {REF} {Length: 3886} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.6]; Receptor family ligand binding region [PF01094.30, score=53.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=22.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=160, Expect=8e-40]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=6e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=152, Expect=3e-37]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=160, Expect=4e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=153, Expect=6e-38]} {Dmel: FBgn0039927, CG11155, [Score=179, Expect=3e-46]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=257, Expect=5e-78]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019556 {REF} {Length: 4135} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.5]; Receptor family ligand binding region [PF01094.30, score=39.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=19.4]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=155, Expect=3e-38]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=8e-37]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=154, Expect=5e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=149, Expect=1e-36]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=149, Expect=1e-36]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=147, Expect=4e-36]} {Dmel: FBgn0039927, CG11155, [Score=169, Expect=3e-43]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=259, Expect=1e-78]} {RNA1509_10728} {RNA1310_31364} {RNA815_8415.1} |
28. | MligTC455_31173 | 106 | 2.2 | Mlig455_014341 | Neo: - Age: logFC(26M/2M)=-0.733 Region-enriched R7: 6.726/0.00000 |
1.869 | - | - | - | - | 0.913 | 0.956 | Mlig455_014341 {REF} {Length: 1841} {Pfam: Methyltransferase domain [PF13383.8, score=20.2]} {Smed: dd_Smed_v6_3811_0_1, dd_Smed_v6_3811_0_1, [Score=95.9, Expect=1e-21]} {RNA1509_59112} {RNA1310_31222} {RNA815_14954} | |
29. | MligTC455_38826 | 244 | 5.08 | Mlig455_059316 | Neo: - Age: Up-Down-Up Region-enriched R8: 3.511/0.00478 |
RDX | 1.867 | 0.965 | - | - | - | - | 0.902 | Mlig455_059316 {REF} {Length: 3395} {Pfam: Ezrin/radixin/moesin family [PF00769.21, score=106.5]; FERM C-terminal PH-like domain [PF09380.12, score=87.8]; FERM central domain [PF00373.20, score=83.0]; FERM N-terminal domain [PF09379.12, score=66.5]} {Human: ENSG00000137710, RDX, radixin, [RH, Score=589, Expect=0.0]; ENSG00000092820, EZR, ezrin, [RH, Score=577, Expect=0.0]; ENSG00000147065, MSN, moesin, [RH, Score=561, Expect=0.0]} {Mouse: ENSMUSG00000032050, Rdx, radixin, [RH, Score=586, Expect=0.0]; ENSMUSG00000031207, Msn, moesin, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0011661, Moe, Moesin, [RH, Score=514, Expect=5e-174]} {Celegans: WBGene00001333, erm-1, ERM-1B; Ezrin/Radixin/Moesin, [Score=545, Expect=0.0]} {Smed: dd_Smed_v6_8101_0_1, dd_Smed_v6_8101_0_1, [Score=504, Expect=7e-172]} {RNA1509_50666} {RNA1310_19690} {RNA815_6880} |
30. | MligTC455_49094 | 59 | 1.22 | Mlig455_065396 | Neo: - Age: - |
RERGL | 1.864 | 0.968 | - | - | - | - | 0.896 | Mlig455_065396 {REF} {Length: 1449} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=61.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=25.4]} {Human: ENSG00000111404, RERGL, RERG like, [Score=80.5, Expect=7e-18]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=80.1, Expect=7e-18]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=84.7, Expect=1e-19]} {Dmel: FBgn0035711, CG8519, [Score=69.3, Expect=4e-14]} {Celegans: WBGene00004309, rap-3, RAP homolog (Vertebrate Rap GTPase family), [Score=59.3, Expect=1e-10]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=80.1, Expect=3e-18]} {RNA1509_41924} {RNA1310_34154} {RNA815_43516} |
31. | MligTC455_36679 | 4666 | 97.21 | Mlig455_049598 | Neo: - Age: logFC(26M/2M)=-0.429 Region-enriched R8: 3.151/0.00004 |
1.858 | - | - | - | - | 0.897 | 0.961 | Mlig455_049598 {REF} {Length: 1229} {RNA1509_20268, RNA1509_24976} {RNA1310_46724, RNA1509_24976} {RNA1509_24976, RNA815_46768} | |
32. | MligTC455_10178 | 77 | 1.6 | Mlig455_017978 | Neo: - Age: - Region-enriched R7: 6.377/0.00000 |
GRM3 | 1.855 | - | - | - | - | 0.862 | 0.993 | Mlig455_017978 {REF} {Length: 3464} {Pfam: Receptor family ligand binding region [PF01094.30, score=224.4]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=185.8]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=39.1]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [RH, Score=675, Expect=0.0]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=670, Expect=0.0]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=725, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [RH, Score=625, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [RH, Score=803, Expect=0.0]} {RNA1310_41220} |
33. | MligTC455_22889 | 401 | 8.35 | Mlig455_049943 | Neo: - Age: - Region-enriched R8: 2.350/0.00423 |
1.848 | 0.886 | - | - | - | - | 0.962 | Mlig455_049943 {REF} {Length: 4673} {RNA1509_32044} {RNA1310_13599.2, RNA1509_32044} {RNA1509_32044, RNA815_5368.1} | |
34. | MligTC455_39206 | 199 | 4.15 | Mlig455_043443 | Neo: - Age: - Region-enriched R8: 3.157/0.04842 |
DCHS1 | 1.846 | 0.952 | - | 0.894 | - | - | - | Mlig455_043443 {REF} {Length: 8571} {Pfam: Cadherin domain [PF00028.19, score=631.2]; Cadherin-like [PF08266.14, score=47.3]; Cadherin-like [PF16184.7, score=29.1]} {Human: ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=587, Expect=5e-169]} {Mouse: ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=580, Expect=4e-167]} {Dmel: FBgn0284247, ds, dachsous, [Score=515, Expect=9e-147]} {Celegans: WBGene00019994, cdh-1, CaDHerin family, [Score=289, Expect=6e-78]} {Smed: dd_Smed_v6_11744_0_1, dd_Smed_v6_11744_0_1, [Score=226, Expect=7e-59]} {RNA1509_5448} {RNA1310_281} {RNA815_1002} |
35. | MligTC455_38827 | 168 | 3.49 | Mlig455_065185 | Neo: - Age: - Region-enriched R8: 3.346/0.01415 |
RDX | 1.844 | 0.976 | - | - | - | - | 0.868 | Mlig455_065185 {REF} {Length: 3409} {Pfam: Ezrin/radixin/moesin family [PF00769.21, score=106.5]; FERM C-terminal PH-like domain [PF09380.12, score=87.8]; FERM central domain [PF00373.20, score=83.0]; FERM N-terminal domain [PF09379.12, score=66.5]} {Human: ENSG00000137710, RDX, radixin, [RH, Score=589, Expect=0.0]; ENSG00000092820, EZR, ezrin, [RH, Score=577, Expect=0.0]; ENSG00000147065, MSN, moesin, [RH, Score=561, Expect=0.0]} {Mouse: ENSMUSG00000032050, Rdx, radixin, [RH, Score=586, Expect=0.0]; ENSMUSG00000031207, Msn, moesin, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0011661, Moe, Moesin, [RH, Score=514, Expect=5e-174]} {Celegans: WBGene00001333, erm-1, ERM-1B; Ezrin/Radixin/Moesin, [Score=545, Expect=0.0]} {Smed: dd_Smed_v6_8101_0_1, dd_Smed_v6_8101_0_1, [Score=504, Expect=7e-172]} {RNA1509_50666} {RNA1310_19690} {RNA815_6880} |
36. | MligTC455_40260 | 7083 | 147.57 | Mlig455_058193 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.425 Region-enriched R7: 5.743/0.00000 Regeneration-depleted BL: -13.476 |
AVP | 1.843 | - | - | - | - | 0.845 | 0.998 | Mlig455_058193 {REF} {Length: 1929} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=58.6]} {Human: ENSG00000101200, AVP, arginine vasopressin, [RH, Score=58.5, Expect=2e-10]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [RH, Score=63.9, Expect=2e-12]} {RNA1509_15970} {RNA1310_46866} {RNA815_23759} |
37. | MligTC455_52402 | 223 | 4.65 | Mlig455_048722 | Neo: - Age: - Region-enriched R8: 5.458/0.00000 |
1.835 | 0.989 | - | - | - | - | 0.846 | Mlig455_048722 {REF} {Length: 961} {TRANSSPLICED} {RNA1310_39954.1} {RNA815_19596} | |
38. | MligTC455_39858 | 79 | 1.66 | Mlig455_038520 | Neo: - |
NECAB1 | 1.829 | - | - | - | 0.956 | 0.873 | - | Mlig455_038520 {REF} {Length: 1812} {Pfam: EF-hand domain [PF13405.8, score=35.3]; EF hand [PF00036.34, score=33.1]; EF-hand domain pair [PF13499.8, score=27.7]; EF-hand domain pair [PF13833.8, score=27.4]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=26.7]; EF hand [PF13202.8, score=23.2]} {Human: ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [Score=187, Expect=2e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [Score=181, Expect=2e-53]} {RNA1310_5770} {RNA815_27367} |
39. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
1.813 | 0.954 | - | - | - | - | 0.859 | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
40. | MligTC455_54034 | 260 | 5.41 | Mlig455_017202 | Neo: - Age: - Region-enriched R8: 2.476/0.02915 |
CALML3 | 1.807 | 0.847 | - | - | - | - | 0.960 | Mlig455_017202 {REF} {Length: 1789} {Pfam: EF hand [PF00036.34, score=86.0]; EF-hand domain pair [PF13499.8, score=75.1]; EF hand [PF13202.8, score=71.2]; EF-hand domain [PF13405.8, score=67.8]; EF-hand domain pair [PF13833.8, score=53.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.0]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=82.8, Expect=1e-20]; ENSG00000198668, CALM1, calmodulin 1, [Score=79.7, Expect=2e-19]; ENSG00000160014, CALM3, calmodulin 3, [Score=79.7, Expect=2e-19]; ENSG00000143933, CALM2, calmodulin 2, [Score=79.7, Expect=2e-19]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=81.6, Expect=3e-20]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=79.7, Expect=1e-19]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=79.7, Expect=1e-19]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=79.7, Expect=1e-19]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=77.8, Expect=6e-19]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=77.8, Expect=5e-19]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=77.8, Expect=4e-19]} {RNA1509_40737} {RNA1310_63281, RNA1509_40737} {RNA1509_40737, RNA815_19875} |
41. | MligTC455_07393 | 66 | 1.37 | Mlig455_006210 | Neo: - Age: - |
1.805 | - | - | - | - | 0.849 | 0.956 | Mlig455_006210 {REF} {Length: 804} {NoTransDecoderORF} {RNA1310_52033} | |
42. | MligTC455_23946 | 219 | 4.57 | Mlig455_044344 | Neo: - Age: - Region-enriched R8: 3.871/0.00002 Regeneration-downregulated BL: -7.362 Regeneration-depleted BL: -7.362 |
1.803 | - | - | - | - | 0.842 | 0.961 | Mlig455_044344 {REF} {Length: 1011} {RNA1509_17939} {RNA1310_36650.1} {RNA815_9418.1} | |
43. | MligTC455_23599 | 300 | 6.25 | Mlig455_025579 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.645/0.00082 |
FBN2 | 1.801 | 0.988 | - | - | 0.813 | - | - | Mlig455_025579 {REF} {Length: 10696} {Pfam: Calcium-binding EGF domain [PF07645.17, score=312.2]; Complement Clr-like EGF-like [PF12662.9, score=241.1]; Coagulation Factor Xa inhibitory site [PF14670.8, score=125.1]; EGF domain [PF12947.9, score=95.9]; EGF-like domain [PF00008.29, score=59.7]; Human growth factor-like EGF [PF12661.9, score=47.9]; Thrombospondin type 1 domain [PF00090.21, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=21.3]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=250, Expect=2e-65]; ENSG00000166147, FBN1, fibrillin 1, [Score=248, Expect=1e-64]; ENSG00000142449, FBN3, fibrillin 3, [Score=243, Expect=3e-63]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=253, Expect=1e-66]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=251, Expect=5e-66]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=238, Expect=3e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=192, Expect=3e-50]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=294, Expect=3e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
44. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 1.798 | 0.954 | - | - | - | - | 0.844 | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
45. | MligTC455_36963 | 39 | 0.81 | Mlig455_050201 | Neo: - Age: Up-Down-Down |
AVPR1B | 1.797 | 0.837 | - | - | - | - | 0.960 | Mlig455_050201 {REF} {Length: 2792} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=152.5]; Olfactory receptor [PF13853.8, score=29.2]} {Human: ENSG00000198049, AVPR1B, arginine vasopressin receptor 1B, [Score=92.8, Expect=1e-19]} {Mouse: ENSMUSG00000049112, Oxtr, oxytocin receptor, [Score=94.0, Expect=3e-20]} {Dmel: FBgn0025595, AkhR, Adipokinetic hormone receptor, [Score=80.5, Expect=7e-16]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=79.0, Expect=3e-15]} {Smed: dd_Smed_v6_45004_0_1, dd_Smed_v6_45004_0_1, [Score=69.7, Expect=8e-13]} {RNA1310_72444} {RNA815_35126} |
46. | MligTC455_51650 | 92 | 1.93 | Mlig455_036750 | Neo: - Age: - Region-enriched R2: 3.192/0.03650 |
ARL3 | 1.795 | 0.804 | - | - | - | - | 0.991 | Mlig455_036750 {REF} {Length: 2942} {Pfam: ADP-ribosylation factor family [PF00025.23, score=98.6]; G-protein alpha subunit [PF00503.22, score=36.0]; Signal recognition particle receptor beta subunit [PF09439.12, score=35.5]; 50S ribosome-binding GTPase [PF01926.25, score=20.6]; Ras family [PF00071.24, score=20.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=19.6]} {Human: ENSG00000138175, ARL3, ADP ribosylation factor like GTPase 3, [Score=81.3, Expect=2e-18]; ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=81.3, Expect=3e-18]; ENSG00000134287, ARF3, ADP ribosylation factor 3, [Score=78.6, Expect=2e-17]; ENSG00000143761, ARF1, ADP ribosylation factor 1, [Score=78.2, Expect=2e-17]} {Mouse: ENSMUSG00000034936, Arl4d, ADP-ribosylation factor-like 4D, [Score=84.7, Expect=8e-20]; ENSMUSG00000025035, Arl3, ADP-ribosylation factor-like 3, [Score=82.4, Expect=5e-19]; ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=80.9, Expect=2e-18]} {Dmel: FBgn0038916, dnd, dead end, [Score=82.8, Expect=2e-19]} {Celegans: WBGene00000188, arl-3, ADP-ribosylation factor-like protein 3, [Score=86.3, Expect=1e-20]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=102, Expect=3e-27]} {RNA1310_52038} {RNA815_22575.1} |
47. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 1.789 | - | - | 0.809 | 0.980 | - | - | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
48. | MligTC455_48986 | 511 | 10.64 | Mlig455_017301 | Neo: - Age: Down-Up-Down |
TRPM2 | 1.789 | 0.839 | - | - | 0.950 | - | - | Mlig455_017301 {REF} {Length: 4476} {Pfam: SLOG in TRPM [PF18139.3, score=216.0]; SLOG in TRPM, prokaryote [PF18171.3, score=64.9]; Ion transport protein [PF00520.33, score=58.5]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=420, Expect=4e-123]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=441, Expect=2e-130]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=293, Expect=2e-81]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=247, Expect=3e-66]} {Smed: dd_Smed_v6_13119_0_1, dd_Smed_v6_13119_0_1, [RH, Score=627, Expect=0.0]} {RNA1509_8528} {RNA1310_1728.1} {RNA815_888} |
49. | MligTC455_23598 | 236 | 4.92 | Mlig455_025573 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.347/0.00904 Regeneration-downregulated BL: -7.152 Regeneration-depleted BL: -7.152 |
FBN1 | 1.775 | 0.987 | - | - | 0.788 | - | - | Mlig455_025573 {REF} {Length: 8300} {Pfam: Calcium-binding EGF domain [PF07645.17, score=308.8]; Complement Clr-like EGF-like [PF12662.9, score=240.6]; Coagulation Factor Xa inhibitory site [PF14670.8, score=137.8]; EGF domain [PF12947.9, score=103.1]; EGF-like domain [PF00008.29, score=67.3]; Human growth factor-like EGF [PF12661.9, score=42.0]; Thrombospondin type 1 domain [PF00090.21, score=27.9]; MSP1 EGF domain 1 [PF12946.9, score=23.5]} {Human: ENSG00000166147, FBN1, fibrillin 1, [Score=274, Expect=5e-73]; ENSG00000138829, FBN2, fibrillin 2, [Score=265, Expect=2e-70]; ENSG00000142449, FBN3, fibrillin 3, [Score=263, Expect=1e-69]} {Mouse: ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=291, Expect=2e-78]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=235, Expect=8e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=165, Expect=2e-41]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=292, Expect=8e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
50. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
1.775 | 0.954 | - | - | - | - | 0.821 | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
51. | MligTC455_42917 | 35 | 0.73 | Mlig455_051334 | Neo: - Age: - Region-enriched R2: 5.166/0.02531 |
1.772 | - | - | - | 0.822 | 0.950 | - | Mlig455_051334 {REF} {Length: 791} {RNA815_44512} | |
52. | MligTC455_14328 | 585 | 12.19 | Mlig455_035956, Mlig455_058425 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=3.032 Region-enriched R2: 6.210/0.01234 |
CYP2U1 | 1.765 | - | - | - | - | 0.792 | 0.973 | Mlig455_035956 {REF} {Length: 4315} {Pfam: Cytochrome P450 [PF00067.24, score=301.9]} {Human: ENSG00000155016, CYP2U1, cytochrome P450 family 2 subfamily U member 1, [Score=213, Expect=5e-62]; ENSG00000108242, CYP2C18, cytochrome P450 family 2 subfamily C member 18, [Score=205, Expect=9e-60]} {Mouse: ENSMUSG00000032808, Cyp2c38, cytochrome P450, family 2, subfamily c, polypeptide 38, [Score=215, Expect=9e-64]; ENSMUSG00000025003, Cyp2c39, cytochrome P450, family 2, subfamily c, polypeptide 39, [Score=214, Expect=3e-63]; ENSMUSG00000116063, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000027983, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000052914, Cyp2j6, cytochrome P450, family 2, subfamily j, polypeptide 6, [Score=212, Expect=2e-62]; ENSMUSG00000052974, Cyp2f2, cytochrome P450, family 2, subfamily f, polypeptide 2, [Score=208, Expect=5e-61]} {Dmel: FBgn0010383, Cyp18a1, Cytochrome P450-18a1, [Score=179, Expect=5e-50]} {Celegans: WBGene00016697, cyp-33C2, CYtochrome P450 family, [Score=206, Expect=3e-60]} {Smed: dd_Smed_v6_2083_0_1, dd_Smed_v6_2083_0_1, [Score=226, Expect=7e-68]} {RNA1509_49553} {RNA1310_2911.1} {RNA815_12179} Mlig455_058425 {REF} {Length: 2850} {Pfam: Cytochrome P450 [PF00067.24, score=301.9]} {Human: ENSG00000155016, CYP2U1, cytochrome P450 family 2 subfamily U member 1, [Score=213, Expect=5e-62]; ENSG00000108242, CYP2C18, cytochrome P450 family 2 subfamily C member 18, [Score=205, Expect=9e-60]} {Mouse: ENSMUSG00000032808, Cyp2c38, cytochrome P450, family 2, subfamily c, polypeptide 38, [Score=215, Expect=9e-64]; ENSMUSG00000025003, Cyp2c39, cytochrome P450, family 2, subfamily c, polypeptide 39, [Score=214, Expect=3e-63]; ENSMUSG00000116063, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000027983, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000052914, Cyp2j6, cytochrome P450, family 2, subfamily j, polypeptide 6, [Score=212, Expect=2e-62]; ENSMUSG00000052974, Cyp2f2, cytochrome P450, family 2, subfamily f, polypeptide 2, [Score=208, Expect=5e-61]} {Dmel: FBgn0010383, Cyp18a1, Cytochrome P450-18a1, [Score=179, Expect=5e-50]} {Celegans: WBGene00016697, cyp-33C2, CYtochrome P450 family, [Score=206, Expect=3e-60]} {Smed: dd_Smed_v6_2083_0_1, dd_Smed_v6_2083_0_1, [Score=226, Expect=7e-68]} {RNA1509_49553} {RNA1310_2911.1, RNA1509_49553} {RNA1509_49553, RNA815_12179} |
53. | MligTC455_18736 | 89 | 1.86 | Mlig455_042545 | Neo: - Age: - |
1.754 | 0.791 | - | - | - | - | 0.963 | Mlig455_042545 {REF} {Length: 2311} {RNA1310_120410} {RNA815_53233} | |
54. | MligTC455_07394 | 59 | 1.22 | Mlig455_057223 | Neo: Int S/G2/M Age: - |
1.752 | - | - | - | - | 0.950 | 0.802 | Mlig455_057223 {REF} {Length: 738} {NoTransDecoderORF} {RNA1310_52033} | |
55. | MligTC455_36374 | 58 | 1.2 | Mlig455_016115 | Neo: - Age: - |
1.751 | 0.951 | - | - | - | - | 0.800 | Mlig455_016115 {REF} {Length: 4900} {RNA1509_18263} {RNA1310_1232} {RNA815_347} | |
56. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 1.749 | 0.960 | - | - | - | - | 0.789 | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
57. | MligTC455_10024 | 48 | 0.99 | Mlig455_065062 | Neo: - Age: - |
1.747 | - | - | - | 0.772 | - | 0.975 | Mlig455_065062 {REF} {Length: 3160} {RNA1310_7348} {RNA815_14995} | |
58. | MligTC455_11469 | 135 | 2.82 | Mlig455_035767 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.383 Region-enriched R7: 6.061/0.00000 Regeneration-enriched R3: 6.059 |
1.746 | - | - | - | - | 0.779 | 0.967 | Mlig455_035767 {REF} {Length: 694} {RNA1509_15474} {RNA1310_93354} {RNA815_37400.2} | |
59. | MligTC455_40352 | 49 | 1.03 | Mlig455_024410 | Neo: - Age: - |
1.745 | - | - | 0.772 | 0.973 | - | - | Mlig455_024410 {REF} {Length: 1509} {TRANSSPLICED} {RNA1310_29008} {RNA815_41596} | |
60. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
1.745 | - | - | - | 0.773 | 0.972 | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
61. | MligTC455_41028 | 108 | 2.26 | Mlig455_033278 | Neo: - Age: - |
1.743 | - | - | 0.766 | 0.977 | - | - | Mlig455_033278 {REF} {Length: 1134} {Pfam: PAN domain [PF00024.28, score=19.4]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=9e-14]} {RNA1310_31986} {RNA815_17816.2} | |
62. | MligTC455_10215 | 54 | 1.12 | Mlig455_012202, Mlig455_028799 | Neo: - Age: logFC(26M/2M)=-0.429 |
PCDH9, PCDHB16 | 1.741 | - | - | 0.955 | 0.786 | - | - | Mlig455_012202 {REF} {Length: 2809} {Pfam: Cadherin domain [PF00028.19, score=133.3]; Cadherin-like [PF16184.7, score=19.8]} {Human: ENSG00000272674, PCDHB16, protocadherin beta 16, [Score=123, Expect=4e-28]; ENSG00000113211, PCDHB6, protocadherin beta 6, [Score=122, Expect=5e-28]; ENSG00000250120, PCDHA10, protocadherin alpha 10, [Score=122, Expect=1e-27]; ENSG00000204970, PCDHA1, protocadherin alpha 1, [Score=122, Expect=1e-27]; ENSG00000113212, PCDHB7, protocadherin beta 7, [Score=121, Expect=1e-27]; ENSG00000177839, PCDHB9, protocadherin beta 9, [Score=119, Expect=4e-27]; ENSG00000204963, PCDHA7, protocadherin alpha 7, [Score=119, Expect=6e-27]; ENSG00000243232, PCDHAC2, protocadherin alpha subfamily C, 2, [Score=119, Expect=8e-27]; ENSG00000204961, PCDHA9, protocadherin alpha 9, [Score=118, Expect=1e-26]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=117, Expect=4e-26]; ENSG00000138650, PCDH10, protocadherin 10, [Score=117, Expect=3e-26]} {Mouse: ENSMUSG00000103442, Pcdha1, protocadherin alpha 1, [Score=127, Expect=2e-29]; ENSMUSG00000102222, Pcdhga10, protocadherin gamma subfamily A, 10, [Score=127, Expect=1e-29]; ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=126, Expect=5e-29]; ENSMUSG00000102692, Dchs2, dachsous cadherin related 2, [Score=125, Expect=2e-28]; ENSMUSG00000007440, Pcdha11, protocadherin alpha 11, [Score=124, Expect=1e-28]} {Dmel: FBgn0261574, kug, kugelei, [Score=117, Expect=3e-26]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=96.3, Expect=6e-20]} {Smed: dd_Smed_v6_16566_0_2, dd_Smed_v6_16566_0_2, [Score=214, Expect=5e-58]} {RNA1509_32459} {RNA1310_2760.2} {RNA815_22195} Mlig455_028799 {REF} {Length: 4449} {Pfam: Cadherin domain [PF00028.19, score=242.6]; Cadherin-like [PF16184.7, score=24.0]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=234, Expect=1e-62]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=234, Expect=1e-62]; ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=226, Expect=5e-60]} {Dmel: FBgn0001075, ft, fat, [Score=196, Expect=2e-50]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=161, Expect=8e-40]} {Smed: dd_Smed_v6_16566_0_1, dd_Smed_v6_16566_0_1, [RH, Score=349, Expect=1e-103]} {RNA1509_32459} {RNA1310_2760.1, RNA1509_32459} {RNA1509_32459, RNA815_6515} |
63. | MligTC455_22098 | 31 | 0.66 | Mlig455_004396, Mlig455_037219 | Neo: - Age: - |
1.735 | - | - | 0.783 | 0.952 | - | - | Mlig455_004396 {REF} {Length: 1521} {RNA1310_40784} Mlig455_037219 {REF} {Length: 1583} {RNA1310_63625} |
|
64. | MligTC455_06906 | 1854 | 38.62 | Mlig455_010761 | Neo: - Age: Down-Up-Up Region-specific R8: 8.047 Region-enriched R8: 7.100/0.00000 |
1.727 | - | - | - | - | 0.777 | 0.950 | Mlig455_010761 {REF} {Length: 812} {RNA1509_21716} {RNA1310_48870, RNA1509_21716} {RNA1509_21716, RNA815_12215.2} | |
65. | MligTC455_33202 | 92 | 1.92 | Mlig455_016989, Mlig455_021240, Mlig455_062989 | Neo: - Age: - |
FCN2 | 1.725 | 0.969 | - | - | 0.756 | - | - | Mlig455_016989 {REF} {Length: 3214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=143.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=135, Expect=2e-37]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=130, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=128, Expect=1e-33]; ENSMUSG00000026938, Fcna, ficolin A, [Score=126, Expect=1e-33]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=125, Expect=2e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=124, Expect=5e-32]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=122, Expect=2e-32]} {Dmel: FBgn0034160, CG5550, [RH, Score=136, Expect=2e-38]} {Celegans: WBGene00017013, ensh-1, [RH, Score=66.2, Expect=4e-12]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.2, Expect=1e-06]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_021240 {REF} {Length: 2191} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=104, Expect=6e-26]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=99.0, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=98.2, Expect=4e-23]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=97.4, Expect=7e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.1, Expect=3e-23]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=95.5, Expect=3e-22]; ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=94.4, Expect=1e-22]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=93.6, Expect=4e-22]} {Dmel: FBgn0034160, CG5550, [Score=104, Expect=9e-27]} {Celegans: WBGene00017013, ensh-1, [Score=52.8, Expect=8e-08]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.6, Expect=8e-07]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_062989 {REF} {Length: 1896} {NoTransDecoderORF} {RNA1509_54825} {RNA1310_118627, RNA1509_54825} {RNA1509_54825, RNA815_47526} |
66. | MligTC455_23596 | 522 | 10.87 | Mlig455_000430, Mlig455_000493, Mlig455_000531 | Neo: - |
FAT4 | 1.724 | 0.963 | - | - | 0.761 | - | - | Mlig455_000430 {REF} {Length: 4267} {Pfam: Cadherin domain [PF00028.19, score=118.2]; Cadherin-like [PF16184.7, score=29.1]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=128, Expect=3e-29]; ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=127, Expect=6e-29]; ENSG00000120327, PCDHB14, protocadherin beta 14, [Score=123, Expect=2e-28]; ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=122, Expect=2e-27]} {Mouse: ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=139, Expect=6e-33]; ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=138, Expect=2e-32]} {Dmel: FBgn0038439, Cad89D, Cadherin 89D, [Score=160, Expect=9e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=112, Expect=7e-25]} {Smed: dd_Smed_v6_7973_0_1, dd_Smed_v6_7973_0_1, [Score=126, Expect=1e-29]} {RNA1509_18837} {RNA1310_7055.1} {RNA815_6037} Mlig455_000493 {REF} {Length: 4048} {Pfam: Cadherin domain [PF00028.19, score=122.3]; Cadherin-like [PF16184.7, score=30.7]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=136, Expect=9e-32]; ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=133, Expect=7e-31]; ENSG00000120322, PCDHB8, protocadherin beta 8, [Score=131, Expect=1e-30]; ENSG00000120327, PCDHB14, protocadherin beta 14, [Score=130, Expect=1e-30]; ENSG00000107736, CDH23, cadherin related 23, [Score=130, Expect=5e-30]} {Mouse: ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=146, Expect=4e-35]} {Dmel: FBgn0284247, ds, dachsous, [Score=162, Expect=2e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=120, Expect=2e-27]} {Smed: dd_Smed_v6_7973_0_2, dd_Smed_v6_7973_0_2, [Score=130, Expect=7e-31]} {RNA1509_18837} {RNA1310_7055.1} {RNA815_6037} Mlig455_000531 {REF} {Length: 2574} {RNA1509_18837} {RNA1310_7055.2} {RNA815_17974.1} |
67. | MligTC455_50533 | 66 | 1.38 | Mlig455_064328 | Neo: - Age: - |
1.721 | - | - | - | 0.954 | 0.767 | - | Mlig455_064328 {REF} {Length: 838} {RNA1310_88153} {RNA815_57541} | |
68. | MligTC455_11108 | 594 | 12.38 | Mlig455_011501 | Neo: - Age: Down-Down-Down Region-enriched R6: 6.991/0.00992 |
1.718 | - | - | - | - | 0.733 | 0.985 | Mlig455_011501 {REF} {Length: 841} {TRANSSPLICED} {RNA1509_54224} {RNA1310_45118} {RNA815_63517} | |
69. | MligTC455_17557 | 200 | 4.16 | Mlig455_022008, Mlig455_058846 | Neo: - Age: - |
1.718 | 0.968 | - | - | - | - | 0.750 | Mlig455_022008 {REF} {Length: 1560} {TRANSSPLICED} {Pfam: Tap RepA1 leader peptide [PF08048.14, score=36.1]} {Mouse: ENSMUSG00000050463, Krt78, keratin 78, [Score=82.0, Expect=2e-16]} {RNA1509_27850} {RNA1310_61376.1} {RNA815_49532} Mlig455_058846 {REF} {Length: 1582} {TRANSSPLICED} {Pfam: Tap RepA1 leader peptide [PF08048.14, score=35.1]} {RNA1509_27850} {RNA1310_61376.1, RNA1509_27850} {RNA1509_27850, RNA815_49532} |
|
70. | MligTC455_14329 | 326 | 6.78 | Mlig455_038755 | Neo: - Age: logFC(26M/2M)=2.873 |
CYP2U1 | 1.714 | - | - | - | - | 0.989 | 0.725 | Mlig455_038755 {REF} {Length: 2107} {Pfam: Cytochrome P450 [PF00067.24, score=302.2]} {Human: ENSG00000155016, CYP2U1, cytochrome P450 family 2 subfamily U member 1, [Score=211, Expect=2e-61]; ENSG00000108242, CYP2C18, cytochrome P450 family 2 subfamily C member 18, [Score=204, Expect=2e-59]; ENSG00000138115, CYP2C8, cytochrome P450 family 2 subfamily C member 8, [Score=202, Expect=1e-58]} {Mouse: ENSMUSG00000032808, Cyp2c38, cytochrome P450, family 2, subfamily c, polypeptide 38, [Score=213, Expect=1e-62]; ENSMUSG00000025003, Cyp2c39, cytochrome P450, family 2, subfamily c, polypeptide 39, [Score=213, Expect=9e-63]; ENSMUSG00000027983, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=209, Expect=7e-61]; ENSMUSG00000116063, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=209, Expect=7e-61]; ENSMUSG00000052914, Cyp2j6, cytochrome P450, family 2, subfamily j, polypeptide 6, [Score=208, Expect=8e-61]; ENSMUSG00000052974, Cyp2f2, cytochrome P450, family 2, subfamily f, polypeptide 2, [Score=204, Expect=1e-59]; ENSMUSG00000025002, Cyp2c55, cytochrome P450, family 2, subfamily c, polypeptide 55, [Score=204, Expect=1e-59]} {Dmel: FBgn0010383, Cyp18a1, Cytochrome P450-18a1, [Score=176, Expect=9e-49]} {Celegans: WBGene00016697, cyp-33C2, CYtochrome P450 family, [Score=206, Expect=1e-60]} {Smed: dd_Smed_v6_2083_0_1, dd_Smed_v6_2083_0_1, [Score=230, Expect=2e-69]} {RNA1509_33783} {RNA1310_2911.1, RNA1509_33783} {RNA1509_33783, RNA815_12179} |
71. | MligTC455_19211 | 107 | 2.23 | Mlig455_052588 | Neo: - Age: - Region-enriched R8: 3.795/0.01587 |
1.714 | 0.978 | - | - | - | - | 0.736 | Mlig455_052588 {REF} {Length: 2340} {Celegans: WBGene00019180, H10D18.5, [RH, Score=62.4, Expect=6e-11]} {Smed: dd_Smed_v6_10251_0_1, dd_Smed_v6_10251_0_1, [RH, Score=95.9, Expect=2e-23]} {RNA1509_8096} {RNA1310_25906} {RNA815_14581.1} | |
72. | MligTC455_12970 | 132 | 2.76 | Mlig455_022445 | Neo: - Age: logFC(26M/2M)=-1.642 |
1.707 | - | - | 0.757 | 0.950 | - | - | Mlig455_022445 {REF} {Length: 1567} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=21.7]} {RNA1509_43359} {RNA1310_32360, RNA1509_43359} {RNA1509_43359, RNA815_34556} | |
73. | MligTC455_26366 | 75 | 1.56 | Mlig455_013893 | Neo: - Age: - |
NSUN7 | 1.705 | - | - | - | 0.724 | - | 0.981 | Mlig455_013893 {REF} {Length: 1904} {Human: ENSG00000179299, NSUN7, NOP2/Sun RNA methyltransferase family member 7, [Score=167, Expect=4e-45]} {Mouse: ENSMUSG00000029206, Nsun7, NOL1/NOP2/Sun domain family, member 7, [Score=164, Expect=3e-44]} {Dmel: FBgn0266099, CG44836, [Score=72.8, Expect=2e-13]} {Celegans: WBGene00013151, nsun-5, Nop2 (NOP2)/SUN domain family member, [Score=56.2, Expect=2e-08]} {Smed: dd_Smed_v6_30093_0_1, dd_Smed_v6_30093_0_1, [Score=203, Expect=3e-60]} {RNA1310_17601} {RNA815_32144} |
74. | MligTC455_47261 | 1918 | 39.96 | Mlig455_033946 | Neo: - Age: - Region-specific R2: 4.808 Region-enriched R2: 4.545/0.00000 |
1.7 | - | - | 0.742 | 0.958 | - | - | Mlig455_033946 {REF} {Length: 2098} {RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1310_36725.1, RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1509_18239, RNA1509_26992, RNA1509_32368, RNA815_10268.1} | |
75. | MligTC455_46052 | 159 | 3.31 | Mlig455_020714 | Neo: - Age: - Region-enriched R2: 2.603/0.01508 |
TRAF5 | 1.696 | - | - | - | 0.958 | - | 0.738 | Mlig455_020714 {REF} {Length: 919} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=90.5, Expect=3e-20]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=73.6, Expect=8e-15]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=98.6, Expect=1e-23]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=135, Expect=1e-36]} {RNA1310_36792.1} {RNA815_40908} |
76. | MligTC455_10517 | 835 | 17.4 | Mlig455_058529 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.877 Region-enriched R7: 6.217/0.00000 Regeneration-downregulated BL: -10.303 Regeneration-depleted BL: -10.303 |
SCUBE1 | 1.694 | - | - | - | - | 0.744 | 0.950 | Mlig455_058529 {REF} {Length: 1976} {Pfam: Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=128.8]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=69.3]; TNFR/NGFR cysteine-rich region [PF00020.20, score=31.5]; Giardia variant-specific surface protein [PF03302.15, score=22.4]} {Human: ENSG00000159307, SCUBE1, signal peptide, CUB domain and EGF like domain containing 1, [Score=60.5, Expect=4e-09]} {Mouse: ENSMUSG00000109446, Gm9195, predicted gene 9195, [Score=63.9, Expect=3e-10]; ENSMUSG00000038677, Scube3, signal peptide, CUB domain, EGF-like 3, [Score=60.8, Expect=2e-09]} {Dmel: FBgn0031879, uif, uninflatable, [Score=73.9, Expect=2e-13]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=54.3, Expect=2e-07]} {Smed: dd_Smed_v6_3432_0_1, dd_Smed_v6_3432_0_1, [Score=82.8, Expect=1e-17]} {RNA1509_1196, RNA1509_12531, RNA1509_18806, RNA1509_31278, RNA1509_3322} {RNA1310_41041, RNA1509_1196, RNA1509_12531, RNA1509_18806, RNA1509_31278, RNA1509_3322} {RNA1509_1196, RNA1509_12531, RNA1509_18806, RNA1509_31278, RNA1509_3322, RNA815_18334} |
77. | MligTC455_25151 | 165 | 3.44 | Mlig455_040052 | Neo: - Age: Down-Up-Up Region-enriched R8: 4.085/0.00147 |
1.694 | 0.964 | - | - | - | - | 0.730 | Mlig455_040052 {REF} {Length: 2343} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.6]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=22.6]} {Smed: dd_Smed_v6_2982_0_2, dd_Smed_v6_2982_0_2, [Score=94.4, Expect=5e-22]} {RNA1509_20770} {RNA1310_38403} {RNA815_6249} | |
78. | MligTC455_18614 | 342 | 7.13 | Mlig455_021102 | Neo: - Age: logFC(26M/2M)=1.052 Region-specific R2: 6.427 Region-enriched R2: 5.869/0.00003 |
1.69 | - | - | 0.722 | 0.968 | - | - | Mlig455_021102 {REF} {Length: 1417} {RNA1509_43477} {RNA1310_26398} {RNA815_11119} | |
79. | MligTC455_28564 | 383 | 7.97 | Mlig455_010532, Mlig455_061843 | Neo: - Age: - Region-enriched R8: 4.824/0.00000 |
KCNJ12 | 1.686 | 0.968 | - | - | 0.718 | - | - | Mlig455_010532 {REF} {Length: 1728} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=178.4]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=147.1]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=260, Expect=1e-83]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=256, Expect=4e-82]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=261, Expect=3e-84]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=251, Expect=7e-80]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=256, Expect=2e-81]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=246, Expect=5e-78]} {RNA1509_57087} {RNA1310_22528} {RNA815_8424.1} Mlig455_061843 {REF} {Length: 1636} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=194.7]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=167.7]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=314, Expect=6e-104]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=311, Expect=1e-102]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=315, Expect=1e-104]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=301, Expect=1e-98]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=310, Expect=2e-101]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=297, Expect=3e-97]} {RNA1509_57087} {RNA1310_22528} {RNA815_8424.1} |
80. | MligTC455_17187 | 85 | 1.77 | Mlig455_040722 | Neo: - Age: logFC(26M/2M)=-0.644 |
SCNN1B | 1.685 | - | - | - | 0.711 | - | 0.974 | Mlig455_040722 {REF} {Length: 2368} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.4]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=64.3, Expect=5e-10]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_25838_0_1, dd_Smed_v6_25838_0_1, [Score=230, Expect=3e-67]} {RNA1509_57515} {RNA1310_24808, RNA1509_57515} {RNA1509_57515, RNA815_46525} |
81. | MligTC455_19604 | 102 | 2.12 | Mlig455_039324 | Neo: - Age: - |
1.685 | 0.710 | - | - | - | - | 0.975 | Mlig455_039324 {REF} {Length: 2104} {RNA1509_38854} {RNA1310_17874} {RNA815_20097} | |
82. | MligTC455_24061 | 1104 | 23.01 | Mlig455_017234 | Neo: - Age: - |
SNAP25 | 1.684 | - | - | 0.723 | 0.961 | - | - | Mlig455_017234 {REF} {Length: 1658} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_25321, RNA1509_8624} {RNA1310_24253, RNA1509_25321, RNA1509_8624} {RNA1509_25321, RNA1509_8624, RNA815_10439} |
83. | MligTC455_18674 | 260 | 5.42 | Mlig455_028606 | Neo: - Age: - Region-enriched R7: 7.304/0.00000 |
1.678 | - | - | - | - | 0.721 | 0.957 | Mlig455_028606 {REF} {Length: 611} {NoTransDecoderORF} {RNA1509_6595} {RNA1310_37826} {RNA815_29683.1} | |
84. | MligTC455_28563 | 196 | 4.09 | Mlig455_061802 | Neo: - Age: Up-Down-Down Region-enriched R8: 4.606/0.00003 |
KCNJ12 | 1.678 | 0.968 | - | - | 0.710 | - | - | Mlig455_061802 {REF} {Length: 5059} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=194.7]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=168.7]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=315, Expect=3e-104]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=311, Expect=8e-103]; ENSG00000123700, KCNJ2, potassium voltage-gated channel subfamily J member 2, [Score=300, Expect=1e-98]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=316, Expect=6e-105]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=301, Expect=6e-99]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=311, Expect=9e-102]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=296, Expect=4e-97]} {RNA1509_57087} {RNA1310_22528, RNA1509_57087} {RNA1509_57087, RNA815_8424.1} |
85. | MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | 1.676 | - | - | 0.707 | - | - | 0.969 | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |
86. | MligTC455_46201 | 1507 | 31.4 | Mlig455_003536 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=1.432 Region-enriched R7: 4.133/0.00000 Regeneration-downregulated BL: -4.010 Regeneration-depleted BL: -4.010 |
1.674 | - | - | - | - | 0.702 | 0.972 | Mlig455_003536 {REF} {Length: 1316} {RNA1509_40578} {RNA1310_31635.1} {RNA815_27083.1} | |
87. | MligTC455_38828 | 995 | 20.73 | Mlig455_009774, Mlig455_054924 | Neo: - Age: Down-Up-Down Region-enriched R8: 1.773/0.01787 |
CELSR2 | 1.671 | 0.970 | - | - | 0.701 | - | - | Mlig455_009774 {REF} {Length: 2779} {Pfam: Cadherin domain [PF00028.19, score=114.6]} {Human: ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=110, Expect=3e-24]} {Mouse: ENSMUSG00000068740, Celsr2, cadherin, EGF LAG seven-pass G-type receptor 2, [Score=107, Expect=3e-23]} {Dmel: FBgn0039294, Cad96Cb, Cadherin 96Cb, [RH, Score=133, Expect=7e-32]} {Celegans: WBGene00000401, cdh-9, CaDHerin family, [RH, Score=79.7, Expect=3e-15]} {Smed: dd_Smed_v6_14410_0_1, dd_Smed_v6_14410_0_1, [Score=77.0, Expect=2e-14]} {RNA1509_6574} {RNA1310_7530, RNA1509_6574} {RNA1509_6574, RNA815_2409} Mlig455_054924 {REF} {Length: 2736} {Pfam: Cadherin domain [PF00028.19, score=113.4]} {Human: ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=108, Expect=1e-23]} {Mouse: ENSMUSG00000068740, Celsr2, cadherin, EGF LAG seven-pass G-type receptor 2, [Score=104, Expect=2e-22]} {Dmel: FBgn0039294, Cad96Cb, Cadherin 96Cb, [RH, Score=130, Expect=5e-31]} {Celegans: WBGene00000401, cdh-9, CaDHerin family, [RH, Score=82.8, Expect=3e-16]} {Smed: dd_Smed_v6_14410_0_1, dd_Smed_v6_14410_0_1, [Score=78.2, Expect=9e-15]} {RNA1509_57757, RNA1509_6574} {RNA1310_7530, RNA1509_57757} {RNA1509_57757, RNA815_2409} |
88. | MligTC455_18487 | 36 | 0.75 | Mlig455_004379 | Neo: - Age: - |
1.67 | - | - | - | 0.955 | - | 0.715 | Mlig455_004379 {REF} {Length: 1362} {RNA1310_54189} | |
89. | MligTC455_47094 | 240 | 5.01 | Mlig455_014204 | Neo: - Age: logFC(26M/2M)=-0.357 |
1.67 | - | - | 0.709 | 0.961 | - | - | Mlig455_014204 {REF} {Length: 3346} {Smed: dd_Smed_v6_4351_0_1, dd_Smed_v6_4351_0_1, [RH, Score=238, Expect=1e-74]} {RNA1509_35661} {RNA1310_8437, RNA1509_35661} {RNA1509_35661, RNA815_15552} | |
90. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
1.667 | - | - | 0.703 | 0.964 | - | - | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
91. | MligTC455_02412 | 75 | 1.56 | Mlig455_011577 | Neo: - Age: - Region-enriched R6: 6.973/0.00029 |
0.996 | - | - | - | - | - | 0.996 | Mlig455_011577 {REF} {Length: 2541} {RNA1310_57680} {RNA815_62505} | |
92. | MligTC455_55791 | 13 | 0.26 | Mlig455_064674 | Neo: - Age: - |
0.995 | - | - | - | - | - | 0.995 | Mlig455_064674 {REF} {Length: 343} {NoTransDecoderORF} | |
93. | MligTC455_09417 | 82 | 1.7 | Mlig455_024500 | Neo: - Age: - Region-enriched R7: 4.042/0.00059 Regeneration-downregulated R6: -6.946 Regeneration-depleted R6: -6.946 |
0.993 | - | - | - | - | - | 0.993 | Mlig455_024500 {REF} {Length: 803} {NoTransDecoderORF} {RNA1509_15591} {RNA1310_17110} | |
94. | MligTC455_31764 | 62 | 1.28 | Mlig455_006258 | Neo: - Age: Down-Down-Up Region-enriched R8: 4.078/0.01607 |
LMNA | 0.992 | 0.992 | - | - | - | - | - | Mlig455_006258 {REF} {Length: 2636} {Pfam: Intermediate filament protein [PF00038.23, score=111.4]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=87.8, Expect=7e-18]; ENSG00000026025, VIM, vimentin, [Score=84.7, Expect=4e-17]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=86.3, Expect=2e-17]; ENSMUSG00000026728, Vim, vimentin, [Score=85.5, Expect=2e-17]; ENSMUSG00000095241, Gm5478, predicted pseudogene 5478, [Score=82.8, Expect=2e-16]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=93.6, Expect=5e-20]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=165, Expect=1e-44]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=190, Expect=6e-54]} {RNA1509_56508} {RNA1310_5840} {RNA815_9167} |
95. | MligTC455_10816 | 14 | 0.29 | Mlig455_027523, Mlig455_046082, Mlig455_061029 | Neo: - Age: - |
0.991 | - | - | - | - | - | 0.991 | Mlig455_027523 {REF} {Length: 383} {RNA1310_79750} Mlig455_046082 {REF} {Length: 352} Mlig455_061029 {REF} {Length: 475} {RNA1310_79750} |
|
96. | MligTC455_35992 | 16 | 0.34 | Mlig455_065424 | Neo: - Age: - |
0.99 | - | - | - | - | - | 0.990 | Mlig455_065424 {REF} {Length: 2272} {Celegans: WBGene00007723, C25F9.2, [Score=64.3, Expect=2e-12]} {RNA1509_52470} {RNA1310_7224.2} {RNA815_8935} | |
97. | MligTC455_33966 | 34 | 0.72 | Mlig455_032703 | Neo: - Age: - |
0.989 | - | - | - | - | - | 0.989 | Mlig455_032703 {REF} {Length: 907} {Pfam: F5/8 type C domain [PF00754.27, score=32.8]} {Dmel: FBgn0001083, fw, furrowed, [Score=46.6, Expect=8e-06]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=53.1, Expect=4e-09]} {RNA1509_42117} {RNA1310_82261} {RNA815_54270} | |
98. | MligTC455_45968 | 43 | 0.89 | Mlig455_058916 | Neo: - Age: - |
0.989 | - | - | - | - | - | 0.989 | Mlig455_058916 {REF} {Length: 3026} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=53.9]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=29.4]} {Smed: dd_Smed_v6_27761_0_1, dd_Smed_v6_27761_0_1, [RH, Score=105, Expect=7e-25]} {RNA1310_38706} | |
99. | MligTC455_22736 | 174 | 3.62 | Mlig455_036576 | Neo: - Age: - Region-enriched R6: 5.263/0.00000 Regeneration-depleted R6: -8.651 |
PHEX | 0.986 | - | - | - | - | - | 0.986 | Mlig455_036576 {REF} {Length: 3336} {Pfam: Peptidase family M13 [PF01431.23, score=134.4]; Peptidase family M13 [PF05649.15, score=87.9]} {Human: ENSG00000102174, PHEX, phosphate regulating endopeptidase homolog X-linked, [Score=155, Expect=1e-38]; ENSG00000284917, EEF1AKMT4-ECE2, EEF1AKMT4-ECE2 readthrough, [Score=154, Expect=3e-38]; ENSG00000145194, ECE2, endothelin converting enzyme 2, [Score=154, Expect=2e-38]; ENSG00000196549, MME, membrane metalloendopeptidase, [Score=148, Expect=2e-36]} {Mouse: ENSMUSG00000022842, Ece2, endothelin converting enzyme 2, [Score=152, Expect=6e-38]; ENSMUSG00000115293, Gm49333, predicted gene, 49333, [Score=152, Expect=8e-38]; ENSMUSG00000027820, Mme, membrane metallo endopeptidase, [Score=148, Expect=1e-36]; ENSMUSG00000057457, Phex, phosphate regulating endopeptidase homolog, X-linked, [Score=146, Expect=6e-36]} {Dmel: FBgn0031081, Nep3, Neprilysin 3, [Score=135, Expect=2e-32]} {Celegans: WBGene00013926, nep-1, Neprilysin-1, [Score=155, Expect=4e-39]} {Smed: dd_Smed_v6_8276_0_1, dd_Smed_v6_8276_0_1, [Score=149, Expect=3e-37]} {RNA1509_47798} {RNA1310_6773, RNA1509_47798} {RNA1509_47798, RNA815_4414} |
100. | MligTC455_11436 | 40 | 0.83 | Mlig455_032348 | Neo: - Age: - |
0.985 | - | - | - | - | - | 0.985 | Mlig455_032348 {REF} {Length: 2105} {RNA1310_29869} {RNA815_39663} |